Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cell for immunotherapy, including modified nucleic acid construct encoding Wilms tumor gene product

Cell for immunotherapy, including modified nucleic acid construct encoding Wilms tumor gene product

US Patent 10316332 · Granted Jun 11, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modified immunocyte, method for producing modified immunocyte and utilization th2023
Spray chamber, sample atomization and introduction device, analysis device, and 2023
Cell for immunotherapy, including modified nucleic acid construct encoding Wilms2021
Immunotherapy using allo-NKT cells, cells for immunotherapy in which alpha chain2020
Memory invariant NKT cell marker2019
Cell for use in immunotherapy which contains modified nucleic acid construct enc2017
Nebulizer and analyzer2016
Nebulizer and analysis equipment2016
Generating a mature NKT cell from a reprogrammed somatic cell with a T-cell anti2015
Resin composition for bonding foundry sand1983
Resin coated foundry sand using crystalline unsaturated polyester as binder1982
Resin composition for bonding foundry sand1982